ALK rearrangements are extremely rare in GI cancers, with a frequency of <1% in colorectal cancer (4), 0.2% in pancreatic cancer (5), and 0.9% to 2.3% in gastric cancer (1, 6), but may offer personalized treatment strategies in selected patients. Here, ALK is linked to gastric cancer.